Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

This study is enrolling participants by invitation only.

Study NCT00660335 Information provided by Repligen Corporation

First Received: April 15, 2008 Last Updated: January 29, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	September 2009
Estimated Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)